Asia Pharm Group and Orzax Discuss New Manufacturing Complex in Uzbekistan

Business

Uzbek pharmaceutical company Asia Pharm Group is in talks with Turkish pharmaceutical company Orzax on a new investment project in Uzbekistan. The initiative envisages the development of a modern manufacturing complex on a 3-hectare site.

Asia Pharm Group and Orzax Discuss New Manufacturing Complex in Uzbekistan
The project is aimed at expanding local production and strengthening manufacturing capacity in Uzbekistan’s pharmaceutical sector. Its implementation is also expected to create new jobs.

Asia Pharm Group already cooperates with Orzax in the Uzbek market. Since 2024, the company has been the official distributor in Uzbekistan for the Turkish brands ORZAX, OCEAN and DAY2DAY.

In addition, on July 30, 2026, Orzaks İlaç ve Kimya Sanayi Ticaret A.Ş. registered a joint venture in Uzbekistan, ORZAX JV LLC, with registered capital of $1 million. According to the Turkish company’s disclosure, Orzaks holds a 70% stake, while the owner of Asia Pharm holds 30%.

The available source materials do not specify the value of the new manufacturing project, its implementation timeline or the products planned for production at the facility.

Powered by Froala Editor

Share with friends